1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. PASITHEA THERAPEUTICS CORP

Pasithea Therapeutics Corp

XNAS: KTTA

Download real time

1.27 0.00 (0.00%)

86.27% Fall from 52W High

32,682 XNAS Volume

XNAS 04 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
8S
8W
4O
0T
3.4

Market Cap

Low in industry
-0.2

PE TTM

Negative PE TTM
0

PEG TTM

0.2

Price to Book

Low in industry
0.7

Beta 1Year

Very Low volatility


Insider Trading disclosures for Pasithea Therapeutics Corp

The latest disclosure was made by Alfred J Novak in Pasithea Therapeutics Corp where a trade of 750 Common Stock done at an average price of $5.6 was reported to US exchanges on June 12, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Alfred J Novak Director Grant, award, or other acquisition of securities at price $ 5.61 per share. 12 Jun 2024 750 750 - 5.6 4,208 Common Stock
Alfred J Novak Director Grant, award, or other acquisition of securities at price $ 5.62 per share. 12 Jun 2024 2,750 3,500 - 5.6 15,455 Common Stock
Alfred J Novak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 5,000 5,000 - - Stock Option (right to buy)
Daniel Schneiderman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 10,000 10,000 - - Stock Option (right to buy)
Graeme Martin Currie Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 5,938 5,938 - - Stock Option (right to buy)
Emer Leahy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 7,500 7,500 - - Stock Option (right to buy)
Simon Dumesnil Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 7,500 7,500 - - Stock Option (right to buy)
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 15,000 15,000 - - Stock Option (right to buy)
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 11,669 11,669 - - Stock Option (right to buy)
Daniel Schneiderman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 5,927 5,927 - - Stock Option (right to buy)
Lawrence J. Steinman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 7,500 7,500 - - Stock Option (right to buy)
Alfred J Novak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 5,000 5,000 - - Stock Option (right to buy)
Daniel Schneiderman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 10,000 10,000 - - Stock Option (right to buy)
Daniel Schneiderman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 5,927 5,927 - - Stock Option (right to buy)
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 11,669 11,669 - - Stock Option (right to buy)
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 15,000 15,000 - - Stock Option (right to buy)
Simon Dumesnil Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 7,500 7,500 - - Stock Option (right to buy)
Emer Leahy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 7,500 7,500 - - Stock Option (right to buy)
Graeme Martin Currie Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 5,938 5,938 - - Stock Option (right to buy)
Lawrence J. Steinman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 7,500 7,500 - - Stock Option (right to buy)
Lawrence J. Steinman Director Purchase of securities on an exchange or from another person at price $ 0.43 per share. 02 Jun 2023 30,000 1,327,174 - 0.4 12,930 Common Stock
Lawrence J. Steinman Director Grant, award, or other acquisition of securities at price $ 0.98 per share. 28 Nov 2022 5,000 1,287,174 - 1.0 4,900 Common Stock
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 1.02 per share. 23 Nov 2022 1,206 817,206 - 1.0 1,230 Common Stock
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 1.03 per share. 23 Nov 2022 2,000 819,206 - 1.0 2,060 Common Stock
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 1.03 per share. 23 Nov 2022 1,000 816,000 - 1.0 1,030 Common Stock
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 1.00 per share. 23 Nov 2022 5,000 815,000 - 1 5,000 Common Stock
Lawrence J. Steinman Director Grant, award, or other acquisition of securities at price $ 0.99 per share. 22 Nov 2022 5,000 1,282,174 - 1.0 4,950 Common Stock
Simon Dumesnil Director Grant, award, or other acquisition of securities at price $ 1.07 per share. 15 Nov 2022 10,000 10,000 - 1.1 10,700 Common Stock
Simon Dumesnil Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2022 100,000 100,000 - - Stock Option (to acquire Common Stock)
Simon Dumesnil Director Grant, award, or other acquisition of securities at price $ 1.06 per share. 15 Nov 2022 40,000 50,000 - 1.1 42,400 Common Stock
Lawrence J. Steinman Director Grant, award, or other acquisition of securities at price $ 1.10 per share. 26 Oct 2022 5,000 1,277,174 - 1.1 5,500 Common Stock
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 1.07 per share. 21 Oct 2022 4,400 810,000 - 1.1 4,708 Common Stock
Alfred J Novak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2022 100,000 100,000 - - Stock Option (to acquire Common Stock)
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 1.08 per share. 21 Oct 2022 600 805,600 - 1.1 648 Common Stock
Daniel Schneiderman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Oct 2022 300,000 300,000 - - Stock Option (to acquire Common Stock)
Eric Shahinian Member of 10% owner group Purchase of securities on an exchange or from another person at price $ 1.16 per share. 28 Sep 2022 6,710 1,788,415 - 1.2 7,757 Common Stock
Eric Shahinian Member of 10% owner group Purchase of securities on an exchange or from another person at price $ 1.19 per share. 28 Sep 2022 57,647 1,781,705 - 1.2 68,542 Common Stock
Eric Shahinian Member of 10% owner group Purchase of securities on an exchange or from another person at price $ 1.13 per share. 01 Sep 2022 55,646 1,690,803 - 1.1 62,630 Common Stock
Eric Shahinian Member of 10% owner group Purchase of securities on an exchange or from another person at price $ 1.13 per share. 01 Sep 2022 21,748 1,724,058 - 1.1 24,632 Common Stock
Eric Shahinian Member of 10% owner group Purchase of securities on an exchange or from another person at price $ 1.14 per share. 01 Sep 2022 11,507 1,702,310 - 1.1 13,105 Common Stock
Lawrence J. Steinman Director Grant, award, or other acquisition of securities at price $ 1.02 per share. 27 Jun 2022 5,000 1,267,174 - 1.0 5,100 Common Stock
Lawrence J. Steinman Director Grant, award, or other acquisition of securities at price $ 1.00 per share. 27 Jun 2022 5,000 1,262,174 - 1 5,000 Common Stock
Lawrence J. Steinman Director Grant, award, or other acquisition of securities at price $ 1.00 per share. 27 Jun 2022 5,000 1,272,174 - 1 5,000 Common Stock
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.99 per share. 23 Jun 2022 100 803,200 - 1.0 99 Common Stock
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.99 per share. 23 Jun 2022 2,900 802,900 - 1.0 2,880 Common Stock
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.98 per share. 23 Jun 2022 200 803,100 - 1.0 196 Common Stock
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.99 per share. 23 Jun 2022 1,800 805,000 - 1.0 1,789 Common Stock
Lawrence J. Steinman Director Grant, award, or other acquisition of securities at price $ 1.00 per share. 23 Jun 2022 5,000 1,257,174 - 1 5,000 Common Stock
Lawrence J. Steinman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 652,174 1,252,174 - 0 Common Stock
Lawrence J. Steinman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 100,000 100,000 - - Stock option (to acquire common stock)
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2021 200,000 800,000 - 0 Common Stock
Tiago Reis Marques Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2021 200,000 200,000 - - Stock Option (to acquire Common Stock)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters